Cargando…
Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors
The efficacy of chimeric antigen receptor T (CAR-T) cells for solid tumors remains unsatisfactory due to the limited tumor infiltration and immunosuppressive microenvironment. To overcome these limitations, the genetically engineered recombinant oncolytic adenoviruses (OAVs) that conditionally repli...
Autores principales: | Fang, Lin, Yuan, Sen, Wang, Meng, Zhang, Chen, Wang, Xueyan, Li, Hailong, Yang, Jie, Li, Wanjing, Sun, Nan, Zhang, Qi, Zhang, Yuxin, Chai, Dafei, Li, Huizhong, Zheng, Junnian, Wang, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475122/ https://www.ncbi.nlm.nih.gov/pubmed/37660142 http://dx.doi.org/10.1038/s41420-023-01626-4 |
Ejemplares similares
-
Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma
por: Zhang, Chen, et al.
Publicado: (2021) -
iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022) -
Absent in melanoma 2 enhances anti‐tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer
por: Chai, Dafei, et al.
Publicado: (2020) -
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
por: Zhang, Qing, et al.
Publicado: (2017) -
Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer
por: Ang, Lin, et al.
Publicado: (2022)